Guidelines for Osteoporosis in Inflammatory Bowel Disease and Coeliac Disease
NR Lewis & BB Scott
Osteoporosis is a major public health problem because of its potentially severe consequences for both the patient and the health care system if it leads to fracture. It has been estimated that one in two women and one in five men older than 50 years will develop an osteoporotic fracture during the course of their remaining lifetime in the United States  and that in the United Kingdom (UK) osteoporosis causes more than 200,000 fractures per year [2, 3]. Osteoporotic fractures are associated with pain, disability and up to 30% mortality at 1 year in addition to an estimated monetary cost in the UK of more than £1 billion yearly [3–5]. Osteoporosis is likely to become even more common and costly because of the ageing population. Gastroenterologists care for groups of patients at increased risk of osteoporotic fracture, such as those with inflammatory bowel disease (IBD) and coeliac disease. These guidelines review the risks of osteoporosis and fracture in these conditions with a view to identifying subgroups of patients that would benefit from screening and interventions to prevent fractures.